The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics.

Sinha, Michael S; Powers, John H; Kesselheim, Aaron S

Sinha, Michael S; Powers, John H; Kesselheim, Aaron S.

Afiliación

Sinha MS; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Powers JH; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Kesselheim AS; George Washington University School of Medicine, Washington, District of Columbia, USA.

J Infect Dis ; 223(9): 1506-1509, 2021 05 20.

Article en En | MEDLINE | ID: mdl-32827433

Asunto(s)

Antibacterianos; Motivación; Antibacterianos/economía; Antibacterianos/farmacología

Palabras clave

antimicrobial resistance; incentives; new antibiotics; reimbursement

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antibacterianos / Motivación Tipo de estudio: Health_economic_evaluation Idioma: En Revista: J Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google